MiR-627-5p and NR2C2 co-overexpression signifcantly reversed the inhibition effect induced by transfection of agomiR-627-5p alone, revealing that miR-627-5p impaired malignancies of glioma cells by downregulating NR2C2 expression. The gene discussed is NR2C2; the disease is central nervous system cancer.